JP2024510249A5 - - Google Patents
Info
- Publication number
- JP2024510249A5 JP2024510249A5 JP2023556900A JP2023556900A JP2024510249A5 JP 2024510249 A5 JP2024510249 A5 JP 2024510249A5 JP 2023556900 A JP2023556900 A JP 2023556900A JP 2023556900 A JP2023556900 A JP 2023556900A JP 2024510249 A5 JP2024510249 A5 JP 2024510249A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- group
- membered
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163546P | 2021-03-19 | 2021-03-19 | |
| US63/163,546 | 2021-03-19 | ||
| PCT/US2022/020687 WO2022197885A1 (en) | 2021-03-19 | 2022-03-17 | Compositions and methods for treating neurologic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510249A JP2024510249A (ja) | 2024-03-06 |
| JP2024510249A5 true JP2024510249A5 (cg-RX-API-DMAC7.html) | 2025-03-26 |
Family
ID=83320987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556900A Pending JP2024510249A (ja) | 2021-03-19 | 2022-03-17 | 神経疾患を治療するための組成物およびその方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240165077A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4308565A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024510249A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230159546A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117355525A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022239497A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3212092A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL306063A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010831A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022197885A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117945980A (zh) * | 2024-01-24 | 2024-04-30 | 上海健康医学院 | 一种异吲哚硫亚胺类化合物及其制备和作为sigma-2受体抑制剂的应用 |
| WO2026064542A1 (en) * | 2024-09-18 | 2026-03-26 | Cognition Therapeutics, Inc. | 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol fumarate salts in solid forms |
| WO2026119142A1 (zh) * | 2024-12-03 | 2026-06-11 | 浙江径科医药有限公司 | 一种氘代异吲哚啉化合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1294358B1 (en) | 2000-06-28 | 2004-08-18 | Smithkline Beecham Plc | Wet milling process |
| WO2013029057A2 (en) * | 2011-08-25 | 2013-02-28 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| WO2015116923A1 (en) * | 2014-01-31 | 2015-08-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| US20200000822A1 (en) * | 2017-02-23 | 2020-01-02 | Board Of Regents, The University Of Texas System | Methods of treatment for cancer, sterol homeostasis, and neurological diseases |
| ES3063712T3 (en) * | 2017-05-15 | 2026-04-20 | Cognition Therapeutics Inc | Compositions for treating neurodegenerative diseases |
| US20200338045A1 (en) * | 2017-11-01 | 2020-10-29 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| JP2022537581A (ja) * | 2019-06-21 | 2022-08-26 | クラリス コーポレーション | Ppm1阻害剤およびその使用方法 |
| CN110283082A (zh) * | 2019-07-15 | 2019-09-27 | 泰州职业技术学院 | 一种3-苯基丙胺的制备方法 |
-
2022
- 2022-03-17 CA CA3212092A patent/CA3212092A1/en active Pending
- 2022-03-17 US US18/280,565 patent/US20240165077A1/en not_active Abandoned
- 2022-03-17 MX MX2023010831A patent/MX2023010831A/es unknown
- 2022-03-17 EP EP22772183.4A patent/EP4308565A4/en active Pending
- 2022-03-17 JP JP2023556900A patent/JP2024510249A/ja active Pending
- 2022-03-17 CN CN202280035073.7A patent/CN117355525A/zh active Pending
- 2022-03-17 WO PCT/US2022/020687 patent/WO2022197885A1/en not_active Ceased
- 2022-03-17 KR KR1020237035979A patent/KR20230159546A/ko active Pending
- 2022-03-17 AU AU2022239497A patent/AU2022239497A1/en active Pending
- 2022-03-17 IL IL306063A patent/IL306063A/en unknown
-
2026
- 2026-02-04 US US19/529,760 patent/US20260166006A1/en active Pending